Reza Nekouian | Genetics and Molecular Biology | Pioneer Researcher Award

Published on by Citation Awards

Reza Nekouian | Genetics and Molecular Biology | Pioneer Researcher Award

Dr Reza Nekouian, Iran University of Medical Sciences, IUMS, Iran

Dr. Reza Nekouian, a seasoned faculty member at Iran University of Medical Sciences, brings over 17 years of expertise in cancer genetics and molecular diagnostics. Born on March 21, 1978, in Tehran, Iran, he has built a strong reputation in research design, academic teaching, and innovative cancer research solutions. Known for his problem-solving and leadership skills, Dr. Nekouian excels in guiding research teams and translating molecular findings into clinical applications. His academic contributions span across cancer genetics, molecular biology, and personalized medicine. In addition to being a dedicated educator in medical genetics and genetic engineering, he is also widely published in reputable journals. Dr. Nekouian is recognized for his collaborative spirit, exceptional communication, and passion for scientific innovation. His work significantly impacts early cancer detection and personalized treatments, aligning science with real-world health solutions.

Publication Profile

google scholar

Education

Dr. Reza Nekouian received his Ph.D. in Medical Biotechnology from Pune University, India, in 2007, where he specialized in cancer molecular biology and therapeutics. Prior to that, he completed his Master of Science (M.Sc.) in Health Sciences (Genetics) at the University of Pune in 2003. His academic journey reflects a focused pursuit of excellence in biotechnology and genetics, laying the foundation for his later contributions in cancer research and medical education. His studies in India exposed him to a rich scientific environment and equipped him with the latest tools in molecular genetics and biomedical research. These formative years nurtured his deep interest in translational medicine, setting him on a path to combine lab-based innovations with clinical cancer diagnostics. Dr. Nekouian’s educational background continues to fuel his research on biomarkers, cancer therapeutics, and molecular diagnostics, making him a valuable contributor to the global scientific and medical community.

Experience

Dr. Reza Nekouian has served as a faculty member and researcher at Iran University of Medical Sciences (IUMS) since February 2012. His core responsibilities include designing and managing cutting-edge research projects in cancer genetics, molecular diagnostics, and biomarker development for early cancer detection. He also actively contributes to advancing personalized medicine approaches in oncology. As a dedicated educator, Dr. Nekouian teaches theoretical and practical courses in medical genetics and genetic engineering, inspiring the next generation of scientists and clinicians. His professional journey spans over 17 years of impactful work at medical universities and research centers. He is recognized for his skill in resolving complex genetic and molecular research challenges, leading multidisciplinary teams, and publishing groundbreaking findings. With a focus on translational research, he bridges laboratory innovations with patient-centric medical applications, thereby improving diagnostic precision and therapeutic strategies in cancer treatment.

Awards and Honors

Although specific awards are not listed in the profile, Dr. Reza Nekouian’s extensive contributions to cancer genetics, personalized medicine, and molecular diagnostics have earned him academic distinction and professional recognition across Iranian and international research communities. His consistent publication in reputed journals, leadership in high-impact research, and role in educational development underscore his influence in the field. Dr. Nekouian has been instrumental in pioneering research programs and contributing to national strategies for cancer prevention and diagnosis. His invited roles in collaborative projects, advisory panels, and journal editorial activities serve as implicit recognition of his expertise. He is regularly consulted for complex research problem-solving and project development, particularly in molecular biology and biotechnology. Additionally, his leadership in implementing cancer control initiatives in the private health sector highlights his commitment to both scientific excellence and societal health advancement.

Research Focus

Dr. Reza Nekouian’s research centers on cancer genetics, with a specialized focus on the molecular mechanisms of tumorigenesis and biomarker discovery for early detection. His work explores the genetic regulation of cancer progression, using advanced diagnostic tools like circulating microRNAs and liposomal drug delivery systems. He also investigates personalized medicine approaches, including the role of gene expression and polymorphisms in cancer susceptibility and therapeutic response. A recurring theme in his research is the integration of molecular diagnostics with clinical oncology, aiming to improve diagnostic accuracy and treatment precision. Dr. Nekouian has contributed significantly to breast, gastric, and colorectal cancer research, evaluating biomarkers like miRNAs, HLA-G, and FOXP3, and exploring innovative cancer therapies using viral vectors and nanotechnology. His interdisciplinary approach blends molecular biology, bioinformatics, and pharmacogenomics to enhance patient outcomes and reduce cancer mortality through early, personalized interventions.

Publication Top Notes

📄 Evaluation of the in vitro and in vivo effect of liposomal doxorubicin with Newcastle disease virus on 4T1 cell line (2023)
📄 Plasma miR-183-5p as a predictive lymph node metastasis marker in colorectal cancer (2022)
📄 Effect of testosterone enanthate on liver Irs-2 mRNA expression in PCOS model rats (2021)
📄 Meta-analysis of serum HLA-G level accuracy in breast cancer diagnosis (2020)
📄 Expression of angiogenesis-related genes in Iranian breast cancer patients (2020)
📄 Epidemiological study of postsurgical invasive breast cancer cases in Iran (2020)
📄 Use of software in detecting angiogenesis in breast tissue slides (2020)
📄 Meta-analysis of FOXP3 polymorphisms and multiple sclerosis susceptibility (2020)
📄 Evaluation of miR-21 and miR-222 as diagnostic biomarkers for gastric cancer (2019)
📄 Nanocomposite scaffold with MSCs for bone repair applications (2019)
📄 Study on protein-binding malondialdehyde in breast cancer tissues (2019)
📄 Management of biotechnology industry in the West and solutions for Iran (2018)
📄 In vitro effects of Lactobacillus reuteri on gastric cancer progression (2017)
📄 Implementation of private sector cancer prevention programs in Iran (2017)
📄 Study on BRCA1/2 mutations in women with breast cancer family history (2016)
📄 Anti-fibronectin gold nanoparticle biosensor for ECM detection (2014)
📄 Iranian consumers’ shift to functional foods for healthier lifestyle (2014)
📄 FOXP3 mRNA downregulation by Alkanna Frigida extract (2013)
📄 H-semigroup structure on F-offspring of a gene pool (2012)

Shuang Guo | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Citation Awards

Shuang Guo | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr Shuang Guo, Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital: Beijing Tsinghua Changgung Hospital, China

Dr. Shuang Guo is a dedicated postdoctoral researcher at Beijing Tsinghua Changgung Hospital, affiliated with the School of Clinical Medicine at Tsinghua University. With a Ph.D. in Clinical Medicine from the prestigious Huazhong University of Science and Technology, Dr. Guo has contributed significantly to the field of cardiovascular and genetic diseases. Her multidisciplinary research approach bridges clinical practice with cutting-edge molecular science, emphasizing hereditary arrhythmias, hypertension, and vascular disorders. Dr. Guo has published influential articles in international journals and is actively involved in innovation, holding several patents related to vascular health and gastrointestinal treatments. As a passionate investigator and co-developer of novel diagnostic and therapeutic strategies, she consistently pushes the boundaries of translational medicine. Dr. Guo’s dedication to scientific excellence and patient-centered research continues to enhance understanding and treatment of complex hereditary and vascular diseases in China and beyond.

Publication Profile

orcid

Education 

Dr. Shuang Guo earned her Ph.D. in Clinical Medicine from the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, one of China’s top institutions in medical education and biomedical research. During her doctoral training, she cultivated a solid foundation in cardiovascular pathology, molecular diagnostics, and translational medicine. Her academic journey was marked by hands-on clinical exposure combined with deep exploration of hereditary diseases, enabling her to integrate lab-based discoveries with bedside care. The program offered her robust mentorship and multidisciplinary collaboration opportunities that enhanced her clinical insight and research acumen. This rigorous educational experience provided the basis for her continued research excellence and led directly to her postdoctoral appointment at Tsinghua University. Her academic background also includes comprehensive training in medical genetics, vascular physiology, and clinical trial design, which continues to inform her postdoctoral investigations into novel treatments and personalized care for cardiovascular and hereditary disorders.

Experience

Currently serving as a postdoctoral researcher at Beijing Tsinghua Changgung Hospital, affiliated with the School of Clinical Medicine, Tsinghua University, Dr. Shuang Guo focuses on vascular biology, hereditary cardiovascular diseases, and precision medicine. Her postdoctoral work includes conducting high-impact research, co-authoring clinical trials, and filing patents on molecular therapies for gastrointestinal and vascular diseases. She collaborates with a multidisciplinary team of clinicians, biologists, and bioengineers to translate laboratory findings into therapeutic solutions. Before her postdoc, she gained extensive research experience at Huazhong University of Science and Technology, where she contributed to translational cardiovascular studies and clinical case analyses at Union Hospital. Dr. Guo is also actively engaged in manuscript writing, grant applications, and patent development, underscoring her commitment to innovation and collaboration. Her professional journey demonstrates a strong intersection of research excellence and clinical relevance, with a focus on improving diagnostic and therapeutic outcomes in genetically mediated and vascular-related conditions.

Awards and Honors

While specific named awards are not listed, Dr. Shuang Guo’s contributions to the medical and scientific community are demonstrated through her leadership as first author in multiple peer-reviewed journals, co-first authorship in a major JACC publication, and her involvement in five innovative patents related to gastrointestinal and vascular health. Her research has garnered recognition in respected publications such as Genes, Journal of Vascular Surgery, and JACC: Basic to Translational Science, reflecting high scholarly merit. These achievements speak to her excellence in both foundational research and applied clinical studies. Dr. Guo’s role in inventing novel uses of inulin, identifying mutation genes associated with hypercholesterolemia, and contributing to the development of therapeutic applications for short-chain fatty acids highlights her contribution to innovation. Her growing reputation in cardiovascular and hereditary disease research underscores her role as a rising scientific leader. Future recognition is likely as her contributions continue to impact global healthcare.

Research Focus

Dr. Shuang Guo’s research is rooted in clinical and molecular investigation of hereditary cardiovascular and gastrointestinal diseases. Her primary focus areas include genetic arrhythmias, monogenic hypertension, vascular inflammation, and abdominal aortic aneurysms. She is particularly interested in translational research—bridging the gap between genetic findings and clinical applications. Her work explores the therapeutic potential of dietary fibers like inulin and microbiota-derived short-chain fatty acids in modulating immune responses and vascular health. Dr. Guo’s ongoing studies involve identifying novel genetic mutations linked to hypercholesterolemia and other inherited conditions. She applies molecular biology, clinical diagnostics, and bioinformatics to uncover mechanisms underlying disease progression. Her research also emphasizes the role of immune modulation in disease treatment, especially via regulatory T-cell activity in vascular disorders. Through multidisciplinary collaboration, she aims to develop minimally invasive strategies and precision-based therapies to improve patient care, focusing on personalized medicine in complex, genetically-influenced disease models.

Publication Top Notes

  • 📘 Pathogenesis and Clinical Characteristics of Hereditary Arrhythmia Diseases – Genes, 2024.

  • 📗 Selective Minimally Invasive Strategy for Acute Superior Mesenteric Artery Obstruction – Journal of Vascular Surgery, 2025.

  • 📙 Propionate Alleviates Abdominal Aortic Aneurysm by Modulating Colonic Regulatory T-Cell Expansion and Recirculation – JACC: Basic to Translational Science, 2022.

  • 📕 Research Advances in Monogenic Inherited Hypertension – 中国医学前沿杂志(电子版), 2024

Abimbola Arise | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

Published on by Citation Awards

Abimbola Arise | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

Dr. Abimbola Arise, University of Ilorin, Kwara State, Nigeria

Dr. Abimbola Kemisola Arise (née Jayeoba) is an esteemed researcher and academic in Food Science and Technology. Born on July 5, 1977, she currently serves in the Department of Home Economics and Food Science. She began her academic career as an Assistant Lecturer in 2011 and has since contributed significantly to food research, focusing on food safety, protein characterization, and product development. A dedicated scholar, she has published extensively in international journals and authored book chapters on sensory evaluation and functional food properties. Dr. Arise is a passionate mentor and an active member of multiple professional societies, including the Nigerian Institute of Food Science and Technology (NIFST) and the South African Association for Food Science and Technology. She has also received awards for her outstanding research contributions. Her expertise in food biochemistry and technology continues to impact both academia and industry.

Publication Profile

google scholar

Education 🎓

Dr. Abimbola Kemisola Arise (née Jayeoba) is an esteemed researcher and academic in Food Science and Technology. Born on July 5, 1977, she currently serves in the Department of Home Economics and Food Science. She began her academic career as an Assistant Lecturer in 2011 and has since contributed significantly to food research, with a focus on food safety, protein characterization, and product development. A dedicated scholar, she has published extensively in international journals and authored book chapters on sensory evaluation and functional food properties. Dr. Arise is a passionate mentor and an active member of multiple professional societies, including the Nigerian Institute of Food Science and Technology (NIFST) and the South African Association for Food Science and Technology. She has also received awards for her outstanding research contributions. Her expertise in food biochemistry and technology continues to impact both academia and industry, fostering advancements in nutritional science, product innovation, and food safety standards.

Experience

Dr. Arise has over a decade of experience in academia and food research. She joined the University of Ilorin as an Assistant Lecturer in 2011 and has progressed through the ranks due to her research excellence. Her career has been dedicated to teaching and mentoring students in Food Science and Technology, with a strong emphasis on applied research and industry collaboration.She has led multiple research projects focusing on food safety, functional food development, and protein characterization. Dr. Arise also participates in peer review activities, contributing as a reviewer for reputable scientific journals. Beyond academia, she engages with professional organizations and has presented her findings at international and national conferences.Her experience extends to supervising undergraduate and postgraduate students, developing innovative food products, and collaborating with industry professionals to advance food processing and safety standards in Nigeria and beyond.

Awards & Honors

  • 🥇 Best Poster Presenter Award – NIFST Conference, University of Ilorin (2019)

  • 🎖️ Member, Nigerian Women in Agriculture Research & Development (2019–Present)

  • 🎖️ Member, Nigerian Society of Experimental Biology (NISEB) (2013–Present)

  • 🎖️ Member, South African Association for Food Science and Technology (2014–Present)

  • 🎖️ Member, Nigerian Institute of Food Science and Technology (NIFST) (2011–Present)

Dr. Arise has been recognized for her impactful research, securing the Best Poster Award at the 2019 NIFST Conference. She is a distinguished member of several professional bodies, contributing to advancements in food science through research, mentorship, and collaborations. Her professional affiliations reflect her commitment to scientific excellence and continuous learning in the field.

Research Focus

Dr. Abimbola Kemisola Arise’s research primarily focuses on food biochemistry, functional food development, and protein extraction. She specializes in protein characterization and the functional properties of legumes, particularly exploring alternative protein sources such as Bambara groundnut 🥜. Her work in fortified and enriched food products 🌿 aims to enhance nutritional quality, while her expertise in sensory evaluation and consumer acceptability 🍪 ensures that innovative food products meet consumer preferences. She also investigates food preservation and safety techniques 🧫 to improve shelf life and reduce spoilage. Additionally, her research delves into nutritional profiling and the health benefits of indigenous foods 📉, providing insights into their potential role in public health. Dr. Arise’s studies on Moringa-enriched maize flour, Bambara groundnut proteins, and food storage techniques have contributed significantly to functional food science. She is committed to bridging the gap between scientific innovation and practical food solutions, promoting sustainable food processing technologies to minimize waste and maximize nutrient retention.

Publication Top Notes

📝 Journals

1️⃣ Effects of storage conditions and periods on glycoalkaloids content and nutritional value of Solanum tuberosum – Journal of Agricultural Research and Development (2012)
2️⃣ Acceptability and Nutritional Attributes of Moringa oleifera–enriched maize flour – Journal of Agricultural Research and Development (2012)
3️⃣ The effects of addition of moringa leaf waste fibre on proximate and sensory characteristics of cookies – Agrosearch (2013)
4️⃣ Acceptability and sensory characteristics of moringa leaf and moringa-based species in Kwara State – International Journal of Phytofuel and Allied Sciences (2014)
5️⃣ Proximate composition, functional and sensory properties of “TUWO” from maize and Bambara groundnut – Applied Tropical Agriculture (2019)
6️⃣ Comparative studies on amino acid and functional properties of black benniseed and false sesame protein concentrates – Ajayi Crowther Journal of Pure and Applied Sciences (2024)

📖 Book Chapters

7️⃣ Understanding Sensory Evaluation of Food – Food Science and Technology, Walter De Gruyter STEM (2021)
8️⃣ Bambara Groundnut Protein in Food and Potential Industrial Applications – Springer (2021)